Mohamed Bouchahda

Générale de Santé — France

Medicine · Health Sciences

19h-index1.2kcitations78works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(50), Hepatocellular Carcinoma Treatment and Prognosis(36), Cancer Treatment and Pharmacology(21), Lung Cancer Treatments and Mutations(15), Gastric Cancer Management and Outcomes(11)

Publications78 total

Assessing circadian rhythms and chemotherapy safety in remote patients with pancreatic ductal adenocarcinoma (PDAC) using a multidimensional digital platform (MultiDom, NCT04263948).
Journal of Clinical Oncology·2025
Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948)
BMJ Open·2023· 3 citedOpen Access
Nivolumab timing as a major survival predictor in patients with stage IV non–small cell lung cancer.
Journal of Clinical Oncology·2022
A multicenter telemonitoring-telecare study with automatic assessment of physiological parameters and patient-reported outcomes in remote pancreatic cancer patients on mFOLFIRINOX: Interim technology report.
Journal of Clinical Oncology·2022· 1 cited
A Comprehensive Internet-Of-Things (IoT) platform for precision health care and chronotherapy in remote monitoring of patients with chronic diseases (Preprint)
2022Open Access
Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer
Cancers·2022· 83 citedOpen Access
Results from EDIFICE : A French pilot study on COVID-19 and the gut microbiome in a hospital environment
2022· 1 citedOpen Access
Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer
Scientific Reports·2021· 5 citedOpen Access
Efficacy of an anti-EGFR after ctDNA conversion from mutated RAS status of metastatic colorectal cancer: Results of a pilot study.
Journal of Clinical Oncology·2021· 5 cited
Time-dependent efficacy of checkpoint inhibitor nivolumab in metastatic lung cancer patients.
Journal of Clinical Oncology·2021· 2 cited
Impact of assessment frequency of patient-reported outcomes: an observational study using an eHealth platform in cancer patients
Supportive Care in Cancer·2021· 17 cited
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International <scp>EORTC</scp> 05011 Trial
International Journal of Cancer·2020· 30 citedOpen Access
Undetectable<i>RAS</i>-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With<i>RAS</i>-Mutant Metastatic Colorectal Cancer
JCO Precision Oncology·2020· 27 citedOpen Access
Improving FOLFIRINOX safety in pancreatic cancer patients through multidimensional remote monitoring and proactive care using a domomedecine mobile platform.
Journal of Clinical Oncology·2020· 2 cited
Hepatic metastases resection after cetuximab: are we missing something?
The Lancet Oncology·2020· 1 cited
Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial
Cancer Medicine·2020· 63 citedOpen Access
Optimizing FOLFIRINOX tolerability in patients with colorectal cancer through dosing irinotecan in the morning for men and in the afternoon for women.
Journal of Clinical Oncology·2020· 3 cited
Inter- and intra-patient circadian variabilities in eight urinary modified nucleosides excretion in patients with metastatic colorectal cancer
2019Open Access
Undetectable RAS mutant clones in plasma: Possible implication for therapy and prognosis in the patient with RAS mutant metastatic colorectal cancer?
Annals of Oncology·2019
The day after: correlates of patient-reported outcomes with actigraphy-assessed sleep in cancer patients at home (inCASA project)
SLEEP·2019· 19 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Françis Lévi(41), Pasquale F. Innominato(31), René Adam(28), Abdoulaye Karaboué(28), C. Focan(14), Michel Ducreux(11), Sylvie Giacchetti(11), Ayhan Ulusakarya(11), Denis Castaing(8), Valérie Boige(7), Mohamed Hebbar(7), Rosine Guimbaud(7), Sandra Komarzynski(7), Denis Smith(6), Céline Lepère(6), Carlos Carvalho(6), D. Castaing(6), Raphaël Saffroy(6), Qi Huang(6), Jean‐François Morère(6)